Immunization Newsbriefs © Copyright Information Inc., Bethesda, MD. Brought to you by the National Network for Immunization Information (NNii). Visit NNii’s new website at http://www.immunizationinfo.org.

October 12, 2001

“UAB to Study Improvements to Anthrax Vaccine” Associated Press (www.ap.org) (10/11/01)

The University of Alabama at Birmingham (UAB) has been selected by the Centers for Disease Control and Prevention to conduct human trials of a three-dose anthrax vaccination regimen.  The current regimen is six shots given over an 18-month period, and UAB will use a $4.3 million grant to study whether half that number of shots would offer protection against the deadly disease.  A second grant of $100,000 was awarded to Vaxin, a drug company in Birmingham, Ala., that used UAB  technology to develop a patch [vaccine] that would make the storage and distribution of anthrax vaccines easier.

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.